#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Arrhythmogenic right ventricular dysplasia Epilepsy Renal cell carcinoma Alveolar rhabdomyosarcoma Tourette's disorder Malignant central nervous system neoplasm Thymic carcinoma Infective uveitis Neutropenia Oesophageal carcinoma Noonan syndrome Krabbe's disease Squamous cell carcinoma of the vulva Hypersomnia More trials…

    Learn about Rare Diseases

    Castleman’s disease – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Wolfram syndrome – Trials in Disease Noonan syndrome – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Hereditary optic atrophy – Treatment Erdheim-Chester disease – Life with Disease Mucopolysaccharidosis III Von Willebrand’s disease – Trials in Disease Haemolytic uraemic syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    YOHIMBINE HYDROCHLORIDE Vaborbactam Toripalimab Pf-06835375 Irinotecan Azelastine Hydrochloride Mexiletine Hydrochloride Labetalol Hydrochloride Murcidencel Mrna-3210 Sulodexide Acou085 Lisinopril Dihydrate Eprosartan Mesilate Filgotinib Piromelatine Salbutamol Sulfate ZIRCONIUM (89ZR) GIRENTUXIMAB Foscarnet Sodium Hexahydrate Dimethyl Fumarate More therapies…

    Learn about Your Condition

    Limb reduction defect Pneumonia chlamydial Familial mediterranean fever Malformation venous Herpes simplex reactivation Chronic myeloid leukaemia Non-obstructive cardiomyopathy Alcoholism Lymphocyte adoptive therapy Breast cancer female Macular telangiectasia Congenital aplastic anaemia Prodromal Alzheimer's disease Rett syndrome Phenylketonuria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Safety and Effectiveness of DT-DEC01 for Patients with Duchenne Muscular Dystrophy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Poland

  • Study on the Effect of Dexamethasone and Sodium Chloride on Pain After ACL Surgery in Adults

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Ligament operation
    Investigated Drugs:
    • Sodium Chloride
    • Dexamethasone Sodium Phosphate
    Italy

  • Study Comparing Teriparatide and Alendronate for Preventing Bone Fractures in Women Over 65 with Fragile Bones

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • ALENDRONATE SODIUM TRIHYDRATE
    • Teriparatide
    Spain

  • Study on Zoledronic Acid for Patients with Chronic Low Back Pain with Modic Changes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Zoledronic Acid
    • Sodium Chloride
    Norway

  • Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Still’s disease
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Anakinra
    The Netherlands

  • Study of KYV-101, Fludarabine Phosphate, and Cyclophosphamide Monohydrate for Patients with Treatment-Resistant ANCA Vasculitis

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Kyv-101
    • Cyclophosphamide Monohydrate
    • Fludarabine Phosphate
    Germany
Previous Page
1 … 35 36 37 38 39 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!